Topic: Micro-RNA based cancer therapies
Dr. Andreas Bader joined Mirna Therapeutics in December 2007 and has served as Director of Analytical and External Research since January 2012. Previously, he served as the Project Lead of the microRNA therapeutics program at Asuragen. Prior to joining Asuragen, Dr. Bader held a faculty position at The Scripps Research Institute, La Jolla, California, where he also completed his postdoctoral training, focusing on molecular mechanisms of cancer and the identification of novel cancer drug targets. Dr. Bader received his M.S. in biology and his Ph.D. in biochemistry from the University of Innsbruck, Austria.